Skip to content
Screener

Geron GERN Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Exelixis logo
ExelixisEXEL
$00.0%
Incyte logo
IncyteINCY
CTO
Citius Oncology, Inc.CTOR

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$949.45M+9.4%
Enterprise value$1.02B+10.4%
P/S4.6×-170×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
Line itemJUNE 30,2026DECEMBER 31,2025
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value
Common stock, $0.001 par value642640
Additional paid-in capital2,094,4742,080,804
Accumulated deficit(1,876,163)(1,855,841)
Accumulated other comprehensive income (loss)(339)269
Total stockholders' equity218,614225,872

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's common stock, par value (in dollars per share)?
Geron (GERN) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Geron's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude